This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • PEACE-3 Trial
      • PROfound Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • ANKTIVA
      • Bladder Cancer Detection
      • CORE-001 Study
      • EV-302
    • Kidney Cancer
      • ZIRCON
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Shilpa Gupta, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular Cancer
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
      • Practice Guidelines Reviews
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • BOND-003 Cohort P
        • CORE-008
        • IMMORTAL
        • PIVOT-006
      • Kidney Cancer
        • RadiCal
        • SAMURAI
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • CLARIFY
        • ECLIPSE
        • ESCAPE
        • FORT
    • Right Side
      • Prostate Cancer
        • METANOVA
        • NRG-GU 0101
        • PROMISE
        • RTIRE
        • SECuRE
        • SHORTER
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2024
      • SCS AUA 2024
      • ASTRO 2024
      • IBCN 2024
      • ESMO 2024
    • All Conferences
      • View All
    • Quick Takes
      • ESMO 2024
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer - Abstract September 21, 2012
Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer - Abstract September 21, 2012
Review of hypofractionated radiotherapy for prostate cancer - Abstract September 21, 2012
Sequencing of cabazitaxel in metastatic castrate-resistant prostate cancer: A case report - Abstract September 21, 2012
A comparison of virtual touch tissue quantification and digital rectal examination for discrimination between prostate cancer and benign prostatic hyperplasia - Abstract September 21, 2012
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: Efficacy and safety of denosumab - Abstract September 21, 2012
Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer: Matched-pair analysis - Abstract September 21, 2012
HPV persistence and its oncogenic role in prostate tumors - Abstract September 21, 2012
Prostate cancer in African American men: Making awareness a priority, a community-based effort September 20, 2012
Author Andrea King Colliers adds humor and a woman’s perspective to men's health issues September 20, 2012
Prostate Education Program (PEP): Inspired pep talks from the Black Barbershop Health Outreach Program Advocate, Stanley K. Frencher, MD, MPH September 20, 2012
Charlie Wilson brings the message home: “Don’t be afraid to talk about prostate cancer.” September 20, 2012
Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner - Abstract September 20, 2012
MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: Initial feasibility in humans - Abstract September 20, 2012
Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer - Abstract September 20, 2012
Factors associated with satisfaction with prostate cancer care: Results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) - Abstract September 20, 2012
Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-Year outcomes - Abstract September 20, 2012
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer - Abstract September 20, 2012
Associations between intake of folate, methionine, and vitamins B-12, B-6 and prostate cancer risk in American veterans - Abstract September 20, 2012
High-intensity focused ultrasound for prostate cancer: Long-term followup and complications rate - Abstract September 20, 2012
Page 1254 of 1451
  • Start
  • Prev
  • 1249
  • 1250
  • 1251
  • 1252
  • 1253
  • 1254
  • 1255
  • 1256
  • 1257
  • 1258
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2025 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free